At the Franco-German Summit on Digital Sovereignty in Berlin, Owkin, in collaboration with Gustave Roussy in France and Charité Comprehensive Cancer Center in Germany, announced the creation of the first pan-European agentic infrastructure designed to make biological data AI-ready and advance biological superintelligence. This initiative represents a key milestone for European digital sovereignty in health, aiming to deliver open, reusable, and immediately actionable outputs for researchers, clinicians, and innovators across the continent.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 4 November 2025
The platform will apply advanced AI methods to support biomedical research and drug development, with an initial focus on harmonizing and structuring biological data across Europe to facilitate collaboration. By combining agentic AI systems with cutting-edge data organization techniques, the project aims to develop reasoning models capable of automating and enhancing multiple stages of research and drug discovery. The partners are actively defining the technical and legal frameworks to ensure the highest standards of data protection and security while promoting innovation.
Health Technology Insights: Freenome Names Rob Guigley CCO as Exact Sciences Deal Clears
This initiative emphasizes Europe’s potential to lead globally in AI-native biology, a field still open to competition even as the United States dominates general-purpose AI. Thomas Clozel, MD, Co-Founder and CEO of Owkin, said, “Europe can be number one in biological AI. While the race for general-purpose LLMs has largely been led by American companies, biology-native reasoning systems are still wide open and align with Europe’s strengths in healthcare, academic excellence, and biomedical data.”
Fabrice André, MD, PhD, Director of Research at Gustave Roussy, added, “This project shows how Europe can turn scientific expertise into tangible benefits for patients. By combining cross-border data with advanced AI, discoveries can be translated into clinical outcomes faster, responsibly and securely.” Ulrich Keilholz, MD, Senior Professor at Charité Comprehensive Cancer Center, stated, “True digital sovereignty in health requires trust. This initiative sets new standards for governance and collaboration, ensuring that innovation occurs within European institutions, guided by European values, for the benefit of European patients.”
By uniting leading research institutions, next-generation AI capabilities, and a shared vision for digital sovereignty, this project sets the foundation for biological artificial superintelligence, a transformative domain with the potential to accelerate discoveries, improve patient care, and secure Europe’s leadership in shaping the future of healthcare.
Health Technology Insights: Hammes Healthcare Appoints Justin Franklin as VP in Denver
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
